[1]
2023. EXPERIENCE OF USING THE COMBINED DRUG GRIPPOMIX IN PATIENTS WITH UNCOMPLICATED FORM SARS AND FLU. International Bulletin of Medical Sciences and Clinical Research. 3, 1 (Jan. 2023), 21–25.